Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Inclusion Criteria

• •Aged from 18 to 90 years old;
• •Complete MRI images and clinical data (such as PSA level, Gleason grade, etc.);
• •Prostate cancer detected by PSA or imaging examination, or clinically suspected recurrence after standardized treatment;
• •simultaneous \[68Ga\]Ga-PSMA-D5 and \[68Ga\]Ga-PSMA-11 examinations within two weeks;
• •Willing to undergo surgery or needle biopsy for pathological examination after examination, or confirmed as prostate cancer by histopathology before or after treatment;
• •Sign informed consent.